Get Avalyn Pharma alerts:Net Margins Return on Equity Return on Assets Avalyn Pharma N/A N/A N/A Avalyn Pharma Competitors -5,748.56% -261.30% -48.91%Analyst RecommendationsThis is a summary of recent recommendations and price targets for Avalyn Pharma and its competitors, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avalyn Pharma 0 1 2 2 3.20 Avalyn Pharma Competitors 2262 2436 4249 71 2.24Institutional & Insider OwnershipAvalyn Pharma presently has a consensus price target of $59.00, suggesting a potential upside of 110.41%. Given Avalyn Pharma’s competitors higher possible upside, analysts plainly believe Avalyn Pharma has less favorable growth aspects than its competitors. Gross Revenue Net Income Price/Earnings Ratio Avalyn Pharma N/A N/A -1.28 Avalyn Pharma Competitors $343.57 million -$25.14 million -5.24Avalyn Pharma’s competitors have higher revenue, but lower earnings than Avalyn Pharma. Receive News & Ratings for Avalyn Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalyn Pharma and related companies with MarketBeat.com's FREE daily email newsletter.